Trials / Completed
CompletedNCT06676995
Effects of Transcranial Pulse Stimulation in Parkinson's Disease
Parkinson's Disease: Overall Symptoms Improvement With Transcranial Pulse Stimulation (TPS)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Spaulding Rehabilitation Hospital · Academic / Other
- Sex
- All
- Age
- 40 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The investigators are studying if Transcranial Pulse Stimulation (TPS) can improve various symptoms, including movement problems, thinking abilities, mood, fatigue, freezing while walking, voice quality, and issues with smell and taste. Previous research suggests TPS might help in Alzheimer's disease and could be helpful for Parkinson's as well. Investigators will check if TPS is safe, practical, and if it makes a noticeable difference in these symptoms compared to before the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcranial Pulse Stimulation (TPS) | Transcranial Pulse Stimulation (TPS) is a non invasive brain stimulation technology that applies repetitive single high-pressure ultrashort shockwave pulses within the ultrasound frequency range to stimulate the brain. Subjects will receive 12 TPS sessions conducted three times weekly, for about 40 to 50 minutes/day, over four consecutive weeks. |
Timeline
- Start date
- 2024-12-31
- Primary completion
- 2025-06-27
- Completion
- 2025-07-30
- First posted
- 2024-11-06
- Last updated
- 2025-12-05
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06676995. Inclusion in this directory is not an endorsement.